Judith Wolf, Donald Munroe, Daniel Chan, Robert Bristow, Calaneet Balas

Vermillion has formed a strategic and medical advisory board that it said will be led by Chief Medical Officer Judith Wolf and Chief Science Officer Donald Munroe.

The company named as charter members of the board Daniel Chan; director of Johns Hopkins University School of Medicine's Center for Biomarker Discovery and Translation; Robert Bristow, director of gynecologic oncology and vice-chair for clinical affairs and quality improvement at the University of California, Irvine; and Calaneet Balas, CEO of the Ovarian Cancer National Alliance.